Marketing-authorisation holder Β· Canada
Searchlight Pharma Inc
87 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
1β25 of 87
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ADRENALIN1 mg / ml Β· Solution | Epinephrine | Canada | Authorised | |
| ADRENALIN1 mg / ml Β· Solution | Epinephrine | Canada | Marketed | 1951 |
| ADRENALIN TOPICAL SOLUTION1 mg / ml Β· Solution | Epinephrine | Canada | Marketed | 1951 |
| ANAPROX275 mg Β· Tablet | Naproxen | Canada | Marketed | 1995 |
| ANAPROX DS550 mg Β· Tablet | Naproxen | Canada | Marketed | 1995 |
| ATARAX10 mg / 5 ml Β· Syrup | Hydroxyzine | Canada | Marketed | 1956 |
| CEREBYX75 mg / ml Β· Solution | Fosphenytoin | Canada | Marketed | 2000 |
| CERUBIDINE20 mg / vial Β· Powder For Solution | Daunorubicin | Canada | Marketed | 1971 |
| CHLOROMYCETIN SUCCINATE INJECTION1 g / vial Β· Powder For Solution | Chloramphenicol | Canada | Marketed | 1959 |
| CHOLEDYL EXPECTORANT50 mg / 5 ml + 100 mg / 5 ml Β· Solution | Guaifenesin, Choline theophyllinate | Canada | Marketed | 1981 |
| COLY-MYCIN M150 mg / vial Β· Powder For Solution | Colistin | Canada | Marketed | 1974 |
| DIPENTUM250 mg Β· Capsule | Olsalazine | Canada | Marketed | 1995 |
| DIVIGEL0.1 % Β· Gel | Estradiol | Canada | Marketed | 2015 |
| DIVIGEL0.1 % Β· Gel | Estradiol | Canada | Marketed | 2015 |
| DIVIGEL0.1 % Β· Gel | Estradiol | Canada | Marketed | 2015 |
| ENABLEX7.5 mg Β· Tablet (Extended-Release) | Darifenacin | Canada | Marketed | 2006 |
| ENABLEX15 mg Β· Tablet (Extended-Release) | Darifenacin | Canada | Marketed | 2006 |
| EPSOLAY5 % / w/w Β· Cream | Benzoyl peroxide | Canada | Marketed | 2026 |
| ERFA HYDROQUINONE4 % / w/w Β· Gel | Hydroquinone | Canada | Marketed | 2020 |
| ESTRAGYN VAGINAL CREAM0.1 % / w/w Β· Cream | Estrone | Canada | Marketed | 1987 |
| EVRA35 mcg / 24 hour + 200 mcg / 24 hour Β· Patch (Extended-Release) | Ethinyl estradiol, Norelgestromin | Canada | Marketed | 2003 |
| FAMVIR125 mg Β· Tablet | Famciclovir | Canada | Marketed | 1996 |
| FAMVIR250 mg Β· Tablet | Famciclovir | Canada | Marketed | 1996 |
| FAMVIR500 mg Β· Tablet | Famciclovir | Canada | Marketed | 1995 |
| HALOETTE2.7 mg + 11.7 mg Β· Ring (Slow-Release) | Ethinyl estradiol, Etonogestrel | Canada | Marketed | 2021 |



